132 related articles for article (PubMed ID: 19604234)
21. Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.
Jiang M; Lu H; Lu C; Geng X; Jia Y; Wang P; Qian W; Huang H; Shan X
Med Sci Monit; 2018 Oct; 24():7603-7613. PubMed ID: 30356034
[TBL] [Abstract][Full Text] [Related]
22. Extranodal natural killer/T cell lymphoma, nasal type in the middle cranial fossa: A case report.
Wang H; Xia X; Qian C
Medicine (Baltimore); 2018 Aug; 97(34):e12028. PubMed ID: 30142852
[TBL] [Abstract][Full Text] [Related]
23. [Combination of PD-1 inhibitor and chemotherapy in the treatment of nasal NK/T cell lymphoma: 5 cases report and literature review].
Liu MY; Li YF; Du JW; Dong LH; Wang YS; Gao X; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):420-422. PubMed ID: 29779354
[No Abstract] [Full Text] [Related]
24. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.
Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ
Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771
[TBL] [Abstract][Full Text] [Related]
25. Current treatment approaches for NK/T-cell lymphoma.
Yamaguchi M; Miyazaki K
J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
[TBL] [Abstract][Full Text] [Related]
26. Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding.
Althoff A; Bibliowicz M
Cureus; 2017 May; 9(5):e1260. PubMed ID: 28652944
[TBL] [Abstract][Full Text] [Related]
27. Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.
Xu Y; Wang J; Zhang W; Liu J; Cao X; He A; Chen Y; Gu L; Lei B; Zhang P; Ma X
Med Sci Monit; 2016 Nov; 22():4297-4311. PubMed ID: 27843135
[TBL] [Abstract][Full Text] [Related]
28. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
[TBL] [Abstract][Full Text] [Related]
29. Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus.
Spadigam A; Dhupar A; Syed S; Saluja TS
Indian J Med Paediatr Oncol; 2016; 37(1):6-13. PubMed ID: 27051150
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.
Geng L; Wang X
Int J Clin Exp Med; 2015; 8(9):14656-71. PubMed ID: 26628948
[TBL] [Abstract][Full Text] [Related]
31. Extranodal natural killer/T-cell lymphoma, nasal type: A great pretender.
Spadigam A; Dhupar A; Syed S; Saluja TS
Int J Appl Basic Med Res; 2015; 5(3):214-6. PubMed ID: 26539376
[TBL] [Abstract][Full Text] [Related]
32. Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.
Zhou X; Lu K; Geng L; Li X; Jiang Y; Wang X
Medicine (Baltimore); 2014 Dec; 93(28):e258. PubMed ID: 25526450
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of radiotherapy alone versus radiochemotherapy in IE/IIE extranodal nasal-type natural killer/T cell lymphoma: a meta-analysis.
Deng T; Zhang C; Zhang X; Wu S; Xu Y; Liu S; Chen X
PLoS One; 2014; 9(9):e106577. PubMed ID: 25184382
[TBL] [Abstract][Full Text] [Related]
34. Delayed diagnosis of nasal natural killer/t-cell lymphoma.
Villwock JA; Jones K; Back J; Goyal P
Case Rep Otolaryngol; 2013; 2013():918132. PubMed ID: 24396622
[TBL] [Abstract][Full Text] [Related]
35. Reconstruction of a rare palate defect originating from extranodal natural killer/t-cell lymphoma.
Han SE; Lim SY
Arch Plast Surg; 2013 May; 40(3):291-4. PubMed ID: 23730618
[No Abstract] [Full Text] [Related]
36. Extranodal natural killer/T-cell lymphoma, nasal type: 'midline lethal granuloma.' A case report.
Tlholoe MM; Kotu M; Khammissa RA; Bida M; Lemmer J; Feller L
Head Face Med; 2013 Jan; 9():4. PubMed ID: 23327615
[TBL] [Abstract][Full Text] [Related]
37. Current and future management of NK/T-cell lymphoma based on clinical trials.
Yamaguchi M
Int J Hematol; 2012 Nov; 96(5):562-71. PubMed ID: 23073619
[TBL] [Abstract][Full Text] [Related]
38. Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.
George LC; Rowe M; Fox CP
Curr Hematol Malig Rep; 2012 Dec; 7(4):276-84. PubMed ID: 22983913
[TBL] [Abstract][Full Text] [Related]
39. PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: a case series.
MacDonald SL; Mulroy L; Wilke DR; Burrell S
Radiat Oncol; 2011 Dec; 6():182. PubMed ID: 22208903
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.
Fox CP; Shannon-Lowe C; Rowe M
Herpesviridae; 2011 Sep; 2():8. PubMed ID: 21899744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
